Antibiotic Transport in Resistant Bacteria: Synchrotron UV Fluorescence Microscopy to Determine Antibiotic Accumulation with Single Cell Resolution

A molecular definition of the mechanism conferring bacterial multidrug resistance is clinically crucial and today methods for quantitative determination of the uptake of antimicrobial agents with single cell resolution are missing. Using the naturally occurring fluorescence of antibacterial agents after deep ultraviolet (DUV) excitation, we developed a method to non-invasively monitor the quinolones uptake in single bacteria. Our approach is based on a DUV fluorescence microscope coupled to a synchrotron beamline providing tuneable excitation from 200 to 600 nm. A full spectrum was acquired at each pixel of the image, to study the DUV excited fluorescence emitted from quinolones within single bacteria. Measuring spectra allowed us to separate the antibiotic fluorescence from the autofluorescence contribution. By performing spectroscopic analysis, the quantification of the antibiotic signal was possible. To our knowledge, this is the first time that the intracellular accumulation of a clinical antibitiotic could be determined and discussed in relation with the level of drug susceptibility for a multiresistant strain. This method is especially important to follow the behavior of quinolone molecules at individual cell level, to quantify the intracellular concentration of the antibiotic and develop new strategies to combat the dissemination of MDR-bacteria. In addition, this original approach also indicates the heterogeneity of bacterial population when the same strain is under environmental stress like antibiotic attack.

[1]  H. Nikaido,et al.  Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. , 2012, FEMS microbiology reviews.

[2]  Bruce R. Levin,et al.  Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum , 2012, PLoS pathogens.

[3]  Hiroshi Nikaido,et al.  Efflux-Mediated Drug Resistance in Bacteria , 2012, Drugs.

[4]  Hajo Grundmann,et al.  Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe , 2011, PLoS medicine.

[5]  Linus Sandegren,et al.  Selection of Resistant Bacteria at Very Low Antibiotic Concentrations , 2011, PLoS pathogens.

[6]  J. Pagés,et al.  An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria. , 2011, Current medicinal chemistry.

[7]  E. Batard,et al.  Diffusion of Ofloxacin in the Endocarditis Vegetation Assessed with Synchrotron Radiation UV Fluorescence Microspectrocopy , 2011, PloS one.

[8]  Y. Carmeli,et al.  A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance , 2011, PLoS medicine.

[9]  S. Bonhoeffer,et al.  On Being the Right Size: The Impact of Population Size and Stochastic Effects on the Evolution of Drug Resistance in Hospitals and the Community , 2011, PLoS Pathogens.

[10]  J. Pagés,et al.  Efflux pumps of gram-negative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. , 2011, Advances in enzymology and related areas of molecular biology.

[11]  H. Nikaido Structure and mechanism of RND-type multidrug efflux pumps. , 2011, Advances in enzymology and related areas of molecular biology.

[12]  M. Lidstrom,et al.  The role of physiological heterogeneity in microbial population behavior. , 2010, Nature chemical biology.

[13]  Nico Stuurman,et al.  Computer Control of Microscopes Using µManager , 2010, Current protocols in molecular biology.

[14]  J. Collins,et al.  Bacterial charity work leads to population-wide resistance , 2010, Nature.

[15]  Frank Wien,et al.  Synchrotron UV Fluorescence Microscopy Uncovers New Probes in Cells and Tissues , 2010, Microscopy and Microanalysis.

[16]  L. Washer,et al.  Managing antimicrobial resistance in intensive care units , 2010, Critical care medicine.

[17]  M. Vulić,et al.  Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli , 2010, PLoS biology.

[18]  Daniel Zerbib,et al.  DISCO: a low-energy multipurpose beamline at synchrotron SOLEIL. , 2009, Journal of synchrotron radiation.

[19]  H. Nikaido Multidrug resistance in bacteria. , 2009, Annual review of biochemistry.

[20]  Ned S Wingreen,et al.  Quantifying the Integration of Quorum-Sensing Signals with Single-Cell Resolution , 2009, PLoS biology.

[21]  M. Winterhalter,et al.  The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria , 2008, Nature Reviews Microbiology.

[22]  J. Pagés,et al.  Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. , 2008, Current drug targets.

[23]  D. De Bacquer,et al.  Measuring the impact of multidrug resistance in nosocomial infection , 2007, Current opinion in infectious diseases.

[24]  L. Rice Emerging issues in the management of infections caused by multidrug-resistant gram-negative bacteria. , 2007, Cleveland Clinic journal of medicine.

[25]  J. Pagés,et al.  An Early Response to Environmental Stress Involves Regulation of OmpX and OmpF, Two Enterobacterial Outer Membrane Pore-Forming Proteins , 2007, Antimicrobial Agents and Chemotherapy.

[26]  M. Falagas,et al.  Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? , 2007, International journal of antimicrobial agents.

[27]  K. Poole Efflux pumps as antimicrobial resistance mechanisms , 2007, Annals of medicine.

[28]  L. Piddock Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.

[29]  Urs Utzinger,et al.  Endogenous Fluorescence Spectroscopy of Cell Suspensions for Chemopreventive Drug Monitoring¶ , 2005, Photochemistry and photobiology.

[30]  J. Pagés,et al.  Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. , 2003, Biochemical and biophysical research communications.

[31]  J. Pagés,et al.  The AcrAB-TolC Efflux Pump Contributes to Multidrug Resistance in the Nosocomial Pathogen Enterobacter aerogenes , 2002, Antimicrobial Agents and Chemotherapy.

[32]  J. Pagés,et al.  New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains. , 2001, Journal of medicinal chemistry.

[33]  L. Piddock,et al.  Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. , 2000, The Journal of antimicrobial chemotherapy.

[34]  V. Ricci,et al.  Accumulation of Norfloxacin by Bacteroides fragilis , 2000 .

[35]  B. Wilson,et al.  In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications , 1998, Photochemistry and photobiology.

[36]  J. Pagés,et al.  Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. , 1998, Microbiology.

[37]  L. Gutmann,et al.  Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[38]  N. Georgopapadakou,et al.  Fluorometric assay for fleroxacin uptake by bacterial cells , 1989, Antimicrobial Agents and Chemotherapy.

[39]  N. Georgopapadakou,et al.  Routes of quinolone permeation in Escherichia coli , 1988, Antimicrobial Agents and Chemotherapy.

[40]  J. Bédard,et al.  Accumulation of enoxacin by Escherichia coli and Bacillus subtilis , 1987, Antimicrobial Agents and Chemotherapy.

[41]  S. Mitsuhashi,et al.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa , 1987, Antimicrobial Agents and Chemotherapy.

[42]  J. Zenilman,et al.  In vitro studies simultaneously examining effect of oxacillin on uptake of radiolabeled streptomycin and on associated bacterial lethality in Staphylococcus aureus , 1986, Antimicrobial Agents and Chemotherapy.

[43]  J. Dick,et al.  Determination of norfloxacin and ciprofloxacin concentrations in serum and urine by high-pressure liquid chromatography , 1986, Antimicrobial Agents and Chemotherapy.

[44]  S. Mitsuhashi,et al.  Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli , 1986, Antimicrobial Agents and Chemotherapy.

[45]  B. Joos,et al.  Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine , 1985, Antimicrobial Agents and Chemotherapy.